RFK Jr.'s 'Make America Healthy Again' report worries farmers, Republicans ahead of release
President Donald Trump promised a review within 100 days that would analyze the ramifications that U.S. lifestyle — from the medications prescribed for children to the food served on their school lunch trays — has on childhood diseases like obesity, depression or attention deficit disorder. The report, led by a so-called 'MAHA Commission,' is expected to be released on Thursday.
Farmers and Republicans are nervous about what the report might say about glyphosate, the ingredient commonly used in pesticides sprayed on crops. Kennedy has denied the report will be unfavorable to farmers.
Speaking on the Senate floor on Wednesday, Iowa Republican Sen. Chuck Grassley warned that farmers have reached out to him, upset they have not been able to provide input on the MAHA report ahead of its release.
'I hope there is nothing in the MAHA report that jeopardizes the food supply or the livelihood of farmers,' Grassley said.
Last month, a group of 79 Republicans — including several senators who represent farming states — echoed similar concerns about the report saying in a letter to Kennedy that without the products agricultural 'yields and quantity are negatively impacted.'
Glyphosate has been available for about 50 years and some farmers say it remains essential for controlling weeds without excessive tilling, helping to conserve both soil and fuel.
'There's a reason why we still use: It works,' said Blake Hurst, a Missouri farmer who is past president of the Missouri Farm Bureau.
Kennedy, though, has built a sizeable following over many decades, in part, because of the lawsuits he's waged against corporations, including the company that produced weedkiller Roundup. The World Health Organization has labeled that product's key ingredient, glyphosate, as a probable carcinogen for humans.
On Wednesday a large group of his supporters sent Kennedy a letter calling on the commission to 'hold the chemical industry' accountable in the report, noting that pressure is mounting.
'Evidence is piling up and the risks from pesticide exposure are undeniable,' the letter, signed by 360 self-proclaimed MAHA supporters that include farmers, former Kennedy campaign staffers and those who worked with him at his anti-vaccine nonprofit.
Dave Murphy, a fundraiser for Kennedy's failed presidential bid, said that he submitted studies and comments on pesticides to Trump administration officials for inclusion in the MAHA report but said that there's 'a lot of pressure within Washington' over what the final report says on the issue.
During a senate hearing on Wednesday, Kennedy rebutted concerns from Mississippi Republican Sen. Cindy Hyde-Smith that the report would 'unfairly' target farmers.
'There's not a single word in them that should worry the American farmer,' Kennedy said of his report. 'We are not going to do anything to jeopardize that business model.'
Kennedy was appearing before the senate appropriations committee to discuss the White House's proposed budget, which would give a $500 million boost for Kennedy's 'Make America Healthy Again' initiative. That same proposal also makes deep cuts, including to infectious disease prevention, maternal health and medical research programs.
In February, Trump signed an executive order establishing a Make America Healthy Again Commission tasked with examining the 'threat' that prescription drugs, chemicals and certain food ingredients pose to children.
That review was supposed to be led by several members of the president's cabinet, including Kennedy, Brooke Rollins, the agriculture secretary, Food and Drug Administration Commissioner Marty Makary and Jay Bhattacharya, director of the National Institutes of Health.
Kennedy, who has pledged 'radical transparency' since taking over the nation's health department, never convened a public meeting of the commission. The White House only released brief, edited clips from a single, closed-door meeting of the commission held in March.
The White House did not respond to requests for comment on the report.
—
Associated Press writers David Lieb in Missouri and Michelle L. Price in Washington contributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Dr. Javad Sajan Does First Facial-Feminization with Simultaneous Hair Transplant Procedure
Seattle Plastic Surgeon Performs Nation's First Combined Facial Feminization & Hair Transplant Surgery SEATTLE, WA / / August 5, 2025 / Dr. Javad Sajan, a top Seattle plastic surgeon and founder of Allure Esthetic Plastic Surgery, has made medical history in the U.S. by performing the nation's first facial feminization surgery (FFS) combined with hair transplant in a single operative session. The milestone procedure was performed on Ember Norman and is featured on offering a detailed look at the surgical planning, technique, and outcomes. The entire surgery, including the hair transplant, qualified for coverage under Norman's gender‑affirming insurance plan. As part of a full facial feminization surgery, Dr. Javad Sajan performed a carefully planned combination of skeletal and soft tissue procedures to transform the patient's facial structure and features. The surgery began with upper facial bone contouring, including frontal bone and orbital bone reduction, and a frontal sinus setback to soften and feminize the upper third of the face. A follicular unit transplant of 1,000 grafts was performed to feminize the hairline. To further feminize the upper face, Dr. Sajan performed a brow lift, elevating the brow position for a more open and feminine expression. In the midface, a mid-facelift and rhinoplasty were performed to enhance facial harmony and refine nasal shape and projection. For the lower face, Dr. Sajan completed a lip lift to shorten the philtrum and improve lip aesthetics. This was followed by chin bone reduction and jaw bone reduction to narrow and sculpt the lower facial contour. This comprehensive transformation reflects the precision and artistry involved in advanced facial feminization surgery. The full surgical journey and before-and-after results can be viewed here. These combined procedures eliminate the need for a second surgery, making the healing process easier and more efficient. Key benefits of this approach include: Single anesthesia event and one recovery timeline A lower and more feminine hairline Minimal scarring Who is an ideal candidate for a same-day FFS+ hair transplant? Ideal candidates for simultaneous FFS and hair transplant surgery include healthy transgender or non-binary patients who are medically cleared for general anesthesia, have realistic expectations, and maintain stable hormone levels for at least six months. Is combining the procedures safe? Combining both procedures in a single session is generally safe; however, all surgery and anesthesia have risks. It eliminates the need for a second anesthesia event, minimizes cumulative swelling, and avoids re-entering previously operated areas, such as a freshly feminized forehead, during a later surgery. How long does the surgery take? The combined procedure typically takes 6 to 12 hours, depending on the extent of facial bone reshaping and the number of hair grafts required. About Dr. Javad Sajan and Allure Esthetic Plastic Surgery: Dr. Javad Sajan is a renowned Seattle-based plastic surgeon, known for his leadership in gender-affirming and facial cosmetic surgery. At Allure Esthetic, Dr. Sajan and his team blend advanced techniques with personalized care to deliver exceptional results. Media Contact:Allure Esthetic Plastic SurgeryPhone: 206-209-0988Website: info@ SOURCE: RealDrSeattle View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Why Hims & Hers Health Stock Just Dropped
Key Points Hims & Hers Health stock missed on earnings last night. The company grew sales 73% and profits tripled, but Wall Street wanted more. Hims & Hers also reported negative free cash flow for the first half of the year. 10 stocks we like better than Hims & Hers Health › Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling today, down 6.7% through 10:55 a.m. ET after missing in its second-quarter earnings report last night, on both the top and bottom lines. Heading into the report, analysts forecast Hims & Hers would earn $0.23 per share on $552 million in sales -- but Hims & Hers earned only $0.17 per share, and sales were less than $545 million. Hims & Hers' Q2 earnings But was the news really as bad as it seems? After all, while Hims & Hers "missed" on sales, it did still grow sales 73% year over year. That was twice as fast as it grew subscribers, too (31%), indicating that not only are more customers signing up for the company's services, but they're buying more, too. And while Hims & Hers missed on earnings, too, those earnings per share nearly tripled year over year. Really, the only "bad" number I see in the report concerns free cash flow (FCF). Through the first half of this year, Hims & Hers grew its operating cash flow only 13%, to $90 million (within a couple of percentage points of reported net income). However, the company spent massively on capital expenditures -- more than $100 million -- resulting in negative FCF for the first half of 2025. Investors seem unsure what to make of the news. At one point this morning, the stock had recovered all its losses, and even turned green, before falling back into the red. Is Hims & Hers stock a sell? So how should investors react to this conflicting news? At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more expensive when valued on FCF -- about 103 times. These might be acceptable valuations if earnings were to continue tripling year after year. In fact, though, analysts see profits growing only 13% this year, and perhaps 57% next. For the time being, Hims & Hers stock remains too expensive to buy. Should you buy stock in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Why Hims & Hers Health Stock Just Dropped was originally published by The Motley Fool
Yahoo
27 minutes ago
- Yahoo
Hegseth ‘has great jeans': Defense Department taps into MAGA's obsession over Sydney Sweeney ad
The Department of Defense tapped into the MAGA movement's obsession with the American Eagle advertising campaign featuring actress Sydney Sweeney on Monday afternoon, as it shared an image of Defense Secretary Pete Hegseth's outfit with the caption: '@secdef has great jeans.' Sweeney has faced criticism for the ad campaign, which critics have argued includes racist messaging, provoking outrage from the right in response. Even President Donald Trump jumped into the fray, praising the ad after it was reported that Sweeney is a registered Republican in Florida. Texas Senator Ted Cruz and Vice President JD Vance have also made statements in support of Sweeney. The president addressed reporters on the runway in Allentown, Pennsylvania, on Sunday night. 'She's a registered Republican?' Trump asked. 'Now I love her ad.' Trump took to Truth Social on Monday morning to say that 'Sydney Sweeney, a registered Republican, has the 'HOTTEST' ad out there.' 'It's for American Eagle, and the jeans are 'flying off the shelves,'' he claimed. Critics of the American Eagle ad campaign have accused the company of spreading 'racist' and 'Nazi propaganda.' Some have argued that it pushes eugenic ideals with its wordplay on 'jeans' and 'genes.' Some of those slamming the ad campaign have argued that the two phrases harken back to the debunked racist theory pushed by the Nazis that the human race can be improved via selective breeding. 'Genes are passed down from parents to offspring, often determining traits like hair color, personality, and even eye color,' Sweeney says in one of the ads. 'My jeans are blue,' she adds, before a narrator says, 'Sydney Sweeney has great jeans.' ''Sydney Sweeney Has Great Jeans' is and always was about the jeans,' American Eagle said in response to the criticism. 'Her jeans. Her story.' 'We'll continue to celebrate how everyone wears their AE jeans with confidence, their way,' the statement added. 'Great jeans look good on everyone.' The tweet by the Department of Defense featuring the jeans-clad Secretary of Defense faced mockery on X. 'We're not a serious country anymore,' the group Republicans Against Trump wrote. 'Hey parents, I know your son or daughter maybe in harm's way and doing a lethal job, but triggering the libs is our ultimate goal here at DOD,' said former Illinois Republican Rep. Adam Kinzinger. 'He'll tell you all about them, along with America's top secret attack plans, on a signal group chat,' said Sarah Longwell of The Bulwark. 'I just want a serious government—and particularly a serious Department of Defense—that doesn't waste time or energy shilling for the egos of its leadership with glam shots like this. Don't you? Surely this isn't an unreasonable expectation,' said Heath Mayo, founder of Principles First. Former CNN Pentagon correspondent Barbara Starr asked, 'Is this what the Pentagon thought was important today?'
